Sod Phenylbutyrat/Taurursodiol
Brand name: Relyvrio
Rank #189 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$77.0M
Total Cost
6,152
Total Claims
$77.0M
Total Cost
142
Prescribers
$13K
Cost per Claim
804
Beneficiaries
6,228
30-Day Fills
$542K
Avg Cost/Provider
43
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$77.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $77.0M total
🔎 Data Overview
At $12,520 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $542,403 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $95,797 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Sod Phenylbutyrat/Taurursodiol
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Kelly Gwathmey | Neurology | Henrico, VA | 205 | $2.6M |
| 2 | Jinae Arneklev | Nurse Practitioner | Baltimore, MD | 174 | $2.3M |
| 3 | Merit Cudkowicz | Neurology | Boston, MA | 178 | $2.3M |
| 4 | Daragh Heitzman | Neurology | Dallas, TX | 165 | $2.1M |
| 5 | Ikjae Lee | Neurology | New York, NY | 159 | $2.0M |
| 6 | James Caress | Neurology | Winston Salem, NC | 156 | $1.9M |
| 7 | Rebecca Kuenzler | Neurology | Cleveland, OH | 119 | $1.9M |
| 8 | Brenda Deliz | Neurology | Rio Piedras, PR | 139 | $1.7M |
| 9 | Matthew Elliott | Neurology | Charlottesville, VA | 129 | $1.6M |
| 10 | Simona Treidler | Neurology | Stony Brook, NY | 123 | $1.5M |
| 11 | Carlayne Jackson | Neurology | San Antonio, TX | 116 | $1.5M |
| 12 | Kara Steijlen | Neurology | Rochester, MN | 119 | $1.5M |
| 13 | Juliet Jenkins | Neurology | San Francisco, CA | 110 | $1.4M |
| 14 | Shafeeq Ladha | Neurology | Phoenix, AZ | 110 | $1.3M |
| 15 | Suzann Hobbs | Nurse Practitioner | Greenville, SC | 100 | $1.2M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
| 188 | Celecoxib (Celecoxib) | $77.7M | 1,938,505 |
| 189 | Sod Phenylbutyrat/Taurursodiol (Relyvrio) | $77.0M | 6,152 |
| 190 | Pravastatin Sodium (Pravastatin Sodium) | $76.8M | 4,033,829 |
| 191 | Lanadelumab-Flyo (Takhzyro) | $76.5M | 1,670 |
| 192 | Diltiazem Hcl (Diltiazem 24hr Er (Cd)) | $75.9M | 1,846,124 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology